Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,579 | -66,995 | -24,487 | -35,080 | -42,694 |
| Depreciation Amortization | 1,269 | 836 | 826 | 538 | 229 |
| Accounts receivable | 4,200 | -3,860 | -487 | N/A | N/A |
| Accounts payable and accrued liabilities | -568 | 2,201 | -338 | 497 | -838 |
| Other Working Capital | 2,027 | 9,859 | -1,800 | -535 | 1,635 |
| Other Operating Activity | 8,724 | 19,382 | 7,636 | 6,998 | 11,461 |
| Operating Cash Flow | $-60,927 | $-38,577 | $-18,650 | $-27,582 | $-30,207 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 59,008 | 69,000 | 69,849 |
| PPE Investments | -19 | -362 | -482 | -1,084 | -1,691 |
| Purchase Of Investment | N/A | N/A | -4,485 | -68,914 | -71,738 |
| Investing Cash Flow | $-19 | $-362 | $54,041 | $-998 | $-3,580 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 44,105 | N/A | 4,975 | 34,460 |
| Debt Repayment | -924 | -23 | -43,754 | -5 | N/A |
| Common Stock Issued | 39,792 | 30,307 | 26,901 | 28,676 | 453 |
| Other Financing Activity | -1,140 | -176 | -17 | 0 | 319 |
| Financing Cash Flow | $37,728 | $74,213 | $-16,870 | $33,646 | $35,232 |
| Beginning Cash Position | 69,547 | 34,273 | 15,752 | 10,686 | 9,241 |
| End Cash Position | 46,329 | 69,547 | 34,273 | 15,752 | 10,686 |
| Net Cash Flow | $-23,218 | $35,274 | $18,521 | $5,066 | $1,445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,927 | -38,577 | -18,650 | -27,582 | -30,207 |
| Capital Expenditure | -27 | -362 | -482 | -1,084 | -1,691 |
| Free Cash Flow | -60,954 | -38,939 | -19,132 | -28,666 | -31,898 |